查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1625246

2030 年胞外体市场预测：按产品、来源、技术、最终用户和地区进行的全球分析

Exosomes Market Forecasts to 2030 - Global Analysis By Product (Exosome Isolation Kits, Exosome Detection and Characterization Kits and Other Products), Source, Technique, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球胞外体市场规模为 1.774 亿美元，预计 2030 年将达到 8.8431 亿美元，预测期内复合年增长率为 30.7%。

胞外体是由各种细胞类型分泌到体液中的小型膜结合细胞外囊泡。它们的直径通常为 30 至 150 奈米，携带蛋白质、脂质和核酸等生物活性分子，并作为细胞间通讯载体。胞外体不仅在癌症、神经退化性疾病和感染疾病等病理状况中发挥重要作用，而且在免疫反应和组织修復等生理过程中也发挥重要作用。由于其独特的性能，它在诊断和治疗输送系统中引起了人们的关注，并有望应用于精准医疗。

根据美国癌症协会估计，到2022年终，将有190万新发癌症病例和609,360人死亡。

将应用扩展到药物输送

胞外体具有高生物相容性和低免疫抗原性，可作为标靶药物传递的天然载体。它能够封装 RNA、蛋白质和小分子药物等治疗分子，从而增强治疗效果。此外，胞外体工程的进步提高了载药能力和标靶化精度，正在推动其采用。製药公司越来越多地投资于基于胞外体的药物输送系统，并认识到它们在精准医疗方面的潜力。预计这一趋势将在未来几年显着推动市场成长。

研发成本高

基于胞外体的治疗方法和诊断的开发需要在先进技术、临床试验和监管核准方面进行大量投资。这些成本往往限制小型企业和新兴企业进入市场。此外，较长的开发时间会增加财务风险，令潜在投资者望而却步。不断上升的研发成本也导致最终产品的价格上涨，使医疗保健提供者和患者更难获得这些产品。因此，基于胞外体的创新的整体成长和传播面临严重的延迟和障碍。

罕见疾病的治疗可能性

胞外体作为卓越的天然载体，为几乎没有替代疗法的疾病和药物输送提供了新的解决方案。它跨越血脑障壁等生物屏障的能力增加了效用。此外，胞外体分离和工程的进步正在促进标靶药物的开发。人们对个人化医疗和孤儿药开发的兴趣日益浓厚，推动了该领域的进一步研究和投资。因此，胞外体市场由于其在罕见疾病治疗方面的变革潜力而正在强劲扩张。

智慧财产纠纷

专利纠纷可能会延迟基于胞外体的新治疗方法和诊断工具的开发和商业化。捲入诉讼的公司往往面临诉讼成本增加并转移研发资源。知识产权纠纷也可能导致市场垄断、限制竞争、提高价格。由于大公司持有专利保护，小型企业可能难以进入市场。总体而言，此类衝突将减缓基于胞外体的产品和服务的成长和可近性。

COVID-19 的影响

COVID-19大流行胞外体市场产生了正面影响。这场大流行导致了解病毒的研究工作空前激增。胞外体是参与细胞间通讯的囊泡，经过研究可以更了解病毒的感染机制及其对宿主细胞的影响。这增加了对研究 COVID-19 的胞外体相关研究工具和诊断方法的需求。此外，多种 COVID-19 疫苗已被开发并批准用于大流行期间的紧急使用。

预计外泌胞外体分离套件市场在预测期内将是最大的

由于其从各种生物样本中分离胞外体的有效且可靠的方法，胞外体分离套件盒部分预计将出现良好的增长。这些套件使研究人员能够提取高品质的胞外体，这对于诊断和治疗等下游应用至关重要。随着对非侵入性诊断的需求增加，这些套件支援液态切片这一主要成长领域的进步。此外，对个人化医疗的日益重视进一步增加了对准确的胞外体分离工具的需求。因此，胞外体分离套件领域透过提高胞外体相关研究和应用的精确度和范围，为市场扩张做出了重大贡献。

诊断实验室产业预计在预测期内复合年增长率最高

透过利用胞外体在非侵入性诊断中的潜力，诊断实验室领域预计在预测期内将以最高的复合年增长率成长。胞外体含有蛋白质、脂质和核酸等生物标记物，有助于疾病的早期检测。这些实验室利用先进技术来分离和分析胞外体，从而能够准确诊断癌症、神经退化性疾病和心血管疾病。实验室和生物技术公司之间的合作将促进基于胞外体的创新诊断工具的开发。随着胞外体应用的认识不断增强，诊断实验室在扩大全球胞外体市场方面变得至关重要。

比最大的地区

由于胞外体在诊断、治疗和药物传递方面的应用不断扩大，预计亚太地区将在预测期内占据最大的市场占有率。生物技术的进步和对个人化医疗的日益关注是关键驱动力。中国、日本和印度等国胞外体研究和商业化方面正在取得快速进展。对非侵入性诊断技术的需求以及癌症和神经退化性疾病等疾病盛行率的上升进一步推动了市场扩张。此外，强大的医疗基础设施和不断增加的投资正在增加该地区的市场机会。

复合年增长率最高的地区：

由于生物技术的进步、再生医学研究的增加以及对个人化治疗的需求不断增长，预计北美在预测期内将表现出最高的复合年增长率。胞外体作为 RNA、蛋白质和脂质的载体，在诊断和药物传递系统中极为重要。该市场受益于癌症治疗、神经系统疾病和免疫治疗等领域不断扩大的应用。此外，美国和加拿大研究机构和医疗保健资金的大力支持正在推动创新。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争标基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球胞外体市场：副产品

  • 胞外体分离试剂套件
  • 胞外体检测与表征试剂套件
  • 胞外体疗法
  • 胞外体诊断试剂套件
  • 其他产品

第六章 全球胞外体市场：依来源分类

  • 人源胞外体
  • 动物性胞外体
  • 植物来源胞外体

第七章全球胞外体市场：依技术分类

  • 胞外体分离技术
    • 超速离心
    • 尺寸排阻层析法(SEC)
    • 亲和性和捕获
    • 基于降水的技术
    • 微流体技术
  • 胞外体表征技术
    • 奈米粒子追踪分析 (NTA)
    • 电子显微镜（EM）
    • 蛋白质印迹法
    • 流式细胞技术
    • 酵素免疫分析法测定法 (ELISA)

第八章全球胞外体市场：依最终用户分类

  • 製药和生物製药公司
  • 学术研究所
  • 诊断实验室
  • 合约研究组织（CRO）
  • 医院和诊所
  • 其他最终用户

第九章全球胞外体市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十一章 公司概况

  • Evox Therapeutics
  • Capricor Therapeutics
  • EXO Biologics
  • Aethlon Medical
  • Coya Therapeutics
  • Aegle Therapeutics Corporation
  • Aragen Bioscience
  • RoosterBio, Inc.
  • Bio-Techne
  • Thermo Fisher Scientific, Inc.
  • Danaher
  • Hologic Inc.
Product Code: SMRC28201

According to Stratistics MRC, the Global Exosomes Market is accounted for $177.4 million in 2024 and is expected to reach $884.31 million by 2030 growing at a CAGR of 30.7% during the forecast period. Exosomes are tiny, membrane-bound extracellular vesicles secreted by various cell types into bodily fluids. Typically 30-150 nanometres in diameter, they carry bioactive molecules such as proteins, lipids, and nucleic acids, serving as intercellular communication vehicles. Exosomes play crucial roles in physiological processes, including immune responses and tissue repair, as well as pathological conditions like cancer, neurodegenerative diseases, and infections. Their unique properties have made them a focus in diagnostics and therapeutic delivery systems, offering potential for precision medicine applications.

According to the American Cancer Society, an estimated 1.9 million new cancer cases and 609,360 cancer deaths were recorded by the end of 2022.

Market Dynamics:

Driver:

Growing applications in drug delivery

Exosomes serve as natural carriers for targeted drug delivery, offering high biocompatibility and low immunogenicity. Their ability to encapsulate therapeutic molecules, such as RNA, proteins, and small drugs, enhances treatment efficacy. Moreover, advancements in engineering exosomes to improve drug-loading capacity and targeting precision have fuelled their adoption. Pharmaceutical companies are increasingly investing in exosome-based drug delivery systems, recognizing their potential for precision medicine. This trend is expected to significantly boost market growth in the coming years.

Restraint:

High cost of research and development

Developing exosome-based therapies and diagnostics requires substantial investment in advanced technologies, clinical trials, and regulatory approvals. These expenses often limit the ability of smaller companies and startups to enter the market. Moreover, the long development timeline increases financial risks, discouraging potential investors. High R&D costs also lead to increased prices for end products, making them less accessible to healthcare providers and patients. Consequently, the overall growth and widespread adoption of exosome-based innovations face considerable delays and obstacles.

Opportunity:

Therapeutic potential in rare diseases

Exosomes act as natural carriers for focused providing novel solutions for diseases, drug delivery with few therapy alternatives. Their capacity to traverse biological barriers, such as the blood-brain barrier, increases their usefulness in treating complex uncommon diseases. Furthermore, advances in exosome isolation and engineering have permitted the development of targeted medicines. Growing interest in personalized medicine and orphan drug development further propels research and investment in this field. Consequently, the exosome market is witnessing robust expansion due to its transformative potential in treating rare diseases.

Threat:

Intellectual property disputes

Patent conflicts can delay the development and commercialization of new exosome-based therapies and diagnostic tools. Companies involved in litigation often face increased legal costs, diverting resources from research and development. IP disputes can also lead to exclusivity in the market, limiting competition and driving up prices. Smaller firms may struggle to enter the market due to patent protections held by larger players. Overall, these disputes slow down the growth and accessibility of exosome-based products and services.

Covid-19 Impact

The COVID-19 pandemic positively impacted the exosomes market. The pandemic prompted an unprecedented surge in research efforts to understand the virus. Exosomes, being small vesicles involved in cell communication, were studied to better understand the virus's mechanisms of infection and its effects on host cells. This led to increased demand for exosome-related research tools and diagnostics for studying COVID-19. Additionally, several COVID-19 vaccines were developed and authorized for emergency use during the pandemic.

The exosome isolation kits segment is expected to be the largest during the forecast period

The exosome isolation kits segment is estimated to have a lucrative growth, due to the efficient and reliable methods for isolating exosomes from various biological samples. These kits enable researchers to extract high-quality exosomes, essential for downstream applications such as diagnostics and therapeutics. With increasing demand for non-invasive diagnostic methods, these kits support liquid biopsy advancements, a key growth area. Moreover, the growing emphasis on personalized medicine further drives the need for precise exosome isolation tools. As a result, the exosome isolation kit segment contributes significantly to market expansion by enhancing the accuracy and scope of exosome-related research and applications.

The diagnostic laboratories segment is expected to have the highest CAGR during the forecast period

The diagnostic laboratories segment is anticipated to witness the highest CAGR growth during the forecast period, by leveraging their potential in non-invasive diagnostics. Exosomes contain biomarkers like proteins, lipids, and nucleic acids that aid in detecting diseases at an early stage. These laboratories utilize advanced technologies to isolate and analyze exosomes, enabling precise diagnosis of cancer, neurodegenerative disorders, and cardiovascular diseases. Collaborations between labs and biotech firms enhance the development of innovative exosome-based diagnostic tools. As awareness of exosome applications grows, diagnostic laboratories are becoming pivotal in expanding the exosomes market globally.

Region with largest share:

Asia Pacific is expected to hold the largest market share during the forecast period due to increased applications of exosomes in diagnostics, therapeutics, and drug delivery. Advances in biotechnology and the growing focus on personalized medicine are key drivers. Countries like China, Japan, and India are witnessing rapid advancements in exosome-based research and commercialization. The demand for non-invasive diagnostic techniques and the rising prevalence of diseases such as cancer and neurodegenerative disorders are further fuelling market expansion. Additionally, the presence of a robust healthcare infrastructure and increasing investments are boosting market opportunities in this region.

Region with highest CAGR:

North America is expected to have the highest CAGR over the forecast period, owing to advancements in biotechnology, increasing research in regenerative medicine, and rising demand for personalized therapies. Exosomes, as carriers of RNA, proteins, and lipids, are crucial in diagnostics and drug delivery systems. The market is benefiting from the expanding applications in cancer treatment, neurological disorders, and immunotherapy. Additionally, robust support from research institutions and healthcare funding in the U.S. and Canada is propelling innovation.

Key players in the market

Some of the key players profiled in the Exosomes Market include Evox Therapeutics, Capricor Therapeutics, EXO Biologics, Aethlon Medical, Coya Therapeutics, Aegle Therapeutics Corporation, Aragen Bioscience, RoosterBio, Inc., Bio-Techne, Thermo Fisher Scientific, Inc., Danaher and Hologic Inc.

Key Developments:

In June 2024, EXO Biologics announced ongoing partnerships with multiple entities in Europe and the US, emphasizing their strategy to license the ExoPulse platform to accelerate drug development. This approach allows EXO Biologics to focus on direct drug development while enabling ExoXpert to support other companies through licensing agreements.

In April 2024, ExoXpert, a subsidiary of EXO Biologics, entered a strategic partnership with Neucore Bio. This collaboration focuses on evaluating advanced exosome loading using ExoXpert's ExoPulse platform to optimize the delivery of proprietary payloads into exosomes.

In July 2023, Evox completed the acquisition of Codiak Biosciences' engEx-AAV(TM) technology platform. This acquisition includes all intellectual property rights associated with the technology, which facilitates the active loading of adeno-associated virus (AAV) into exosomes, thereby improving delivery efficacy and shielding AAVs from neutralizing antibodies

Products Covered:

  • Exosome Isolation Kits
  • Exosome Detection and Characterization Kits
  • Exosome Therapeutics
  • Exosome Diagnostic Kits
  • Other Products

Sources Covered:

  • Human-Derived Exosomes
  • Animal-Derived Exosomes
  • Plant-Derived Exosomes

Techniques Covered:

  • Exosome Isolation Techniques
  • Exosome Characterization Techniques

End Users Covered:

  • Pharmaceutical and Biopharmaceutical Companies
  • Academic and Research Institutes
  • Diagnostic Laboratories
  • Contract Research Organizations (CROs)
  • Hospitals and Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Exosomes Market, By Product

  • 5.1 Introduction
  • 5.2 Exosome Isolation Kits
  • 5.3 Exosome Detection and Characterization Kits
  • 5.4 Exosome Therapeutics
  • 5.5 Exosome Diagnostic Kits
  • 5.6 Other Products

6 Global Exosomes Market, By Source

  • 6.1 Introduction
  • 6.2 Human-Derived Exosomes
  • 6.3 Animal-Derived Exosomes
  • 6.4 Plant-Derived Exosomes

7 Global Exosomes Market, By Technique

  • 7.1 Introduction
  • 7.2 Exosome Isolation Techniques
    • 7.2.1 Ultracentrifugation
    • 7.2.2 Size Exclusion Chromatography (SEC)
    • 7.2.3 Immunoaffinity Capture
    • 7.2.4 Precipitation-Based Techniques
    • 7.2.5 Microfluidic Technology
  • 7.3 Exosome Characterization Techniques
    • 7.3.1 Nanoparticle Tracking Analysis (NTA)
    • 7.3.2 Electron Microscopy (EM)
    • 7.3.3 Western Blotting
    • 7.3.4 Flow Cytometry
    • 7.3.5 Enzyme-Linked Immunosorbent Assay (ELISA)

8 Global Exosomes Market, By End User

  • 8.1 Introduction
  • 8.2 Pharmaceutical and Biopharmaceutical Companies
  • 8.3 Academic and Research Institutes
  • 8.4 Diagnostic Laboratories
  • 8.5 Contract Research Organizations (CROs)
  • 8.6 Hospitals and Clinics
  • 8.7 Other End Users

9 Global Exosomes Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Evox Therapeutics
  • 11.2 Capricor Therapeutics
  • 11.3 EXO Biologics
  • 11.4 Aethlon Medical
  • 11.5 Coya Therapeutics
  • 11.6 Aegle Therapeutics Corporation
  • 11.7 Aragen Bioscience
  • 11.8 RoosterBio, Inc.
  • 11.9 Bio-Techne
  • 11.10 Thermo Fisher Scientific, Inc.
  • 11.11 Danaher
  • 11.12 Hologic Inc.

List of Tables

  • Table 1 Global Exosomes Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Exosomes Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Exosomes Market Outlook, By Exosome Isolation Kits (2022-2030) ($MN)
  • Table 4 Global Exosomes Market Outlook, By Exosome Detection and Characterization Kits (2022-2030) ($MN)
  • Table 5 Global Exosomes Market Outlook, By Exosome Therapeutics (2022-2030) ($MN)
  • Table 6 Global Exosomes Market Outlook, By Exosome Diagnostic Kits (2022-2030) ($MN)
  • Table 7 Global Exosomes Market Outlook, By Other Products (2022-2030) ($MN)
  • Table 8 Global Exosomes Market Outlook, By Source (2022-2030) ($MN)
  • Table 9 Global Exosomes Market Outlook, By Human-Derived Exosomes (2022-2030) ($MN)
  • Table 10 Global Exosomes Market Outlook, By Animal-Derived Exosomes (2022-2030) ($MN)
  • Table 11 Global Exosomes Market Outlook, By Plant-Derived Exosomes (2022-2030) ($MN)
  • Table 12 Global Exosomes Market Outlook, By Technique (2022-2030) ($MN)
  • Table 13 Global Exosomes Market Outlook, By Exosome Isolation Techniques (2022-2030) ($MN)
  • Table 14 Global Exosomes Market Outlook, By Ultracentrifugation (2022-2030) ($MN)
  • Table 15 Global Exosomes Market Outlook, By Size Exclusion Chromatography (SEC) (2022-2030) ($MN)
  • Table 16 Global Exosomes Market Outlook, By Immunoaffinity Capture (2022-2030) ($MN)
  • Table 17 Global Exosomes Market Outlook, By Precipitation-Based Techniques (2022-2030) ($MN)
  • Table 18 Global Exosomes Market Outlook, By Microfluidic Technology (2022-2030) ($MN)
  • Table 19 Global Exosomes Market Outlook, By Exosome Characterization Techniques (2022-2030) ($MN)
  • Table 20 Global Exosomes Market Outlook, By Nanoparticle Tracking Analysis (NTA) (2022-2030) ($MN)
  • Table 21 Global Exosomes Market Outlook, By Electron Microscopy (EM) (2022-2030) ($MN)
  • Table 22 Global Exosomes Market Outlook, By Western Blotting (2022-2030) ($MN)
  • Table 23 Global Exosomes Market Outlook, By Flow Cytometry (2022-2030) ($MN)
  • Table 24 Global Exosomes Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2022-2030) ($MN)
  • Table 25 Global Exosomes Market Outlook, By End User (2022-2030) ($MN)
  • Table 26 Global Exosomes Market Outlook, By Pharmaceutical and Biopharmaceutical Companies (2022-2030) ($MN)
  • Table 27 Global Exosomes Market Outlook, By Academic and Research Institutes (2022-2030) ($MN)
  • Table 28 Global Exosomes Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
  • Table 29 Global Exosomes Market Outlook, By Contract Research Organizations (CROs) (2022-2030) ($MN)
  • Table 30 Global Exosomes Market Outlook, By Hospitals and Clinics (2022-2030) ($MN)
  • Table 31 Global Exosomes Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.